With reference to the captioned subject and pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with paragraph A of Part A of Schedule III, please find enclosed the Investor Presentation of the Company. This information shall simultaneously be uploaded on the website of the Company i.e. www.hathway.com This is for your information.
Pursuant to Regulation 30(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we inform you that a conference call on acquisition of Sandoz's dermatology and oral solids businesses is scheduled on 6th September 2018 at 5:30 PM Please find attached the dial-in details of the call. In this connection, we enclose herewith the presentation that would be used in the aforesaid conference call....
A copy of investor presentation of the Company in connection with the same is enclosed herewith and is being uploaded on the Company's website under 'Investors Section'.
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith Presentation on the financial results of the Company for the quarter ended 30th June, 2018.
Further to out letter No. SPARC/Sec/SE/2018-19/011 dated 4th July 2018 on the subject, please find enclosed a copy of the presentation by the Company providing update on NCE & NDDS programs, which is self-explanatory. You are requested to kindly take the same on your record & disseminate the information through your website.